Beating Back the Coronavirus: FDA-Approved Drug Repurposing Pipeline

preview_player
Показать описание
With the goal of rapidly repurposing FDA-approved drugs to treat COVID-19, the Wyss Institute is collaborating with the Frieman Lab at the University of Maryland Medical School and the tenOever Lab at the Icahn School of Medicine at Mount Sinai to establish a multidisciplinary pipeline that can rapidly predict, test, and validate potential treatments.

Credit: Wyss Institute at Harvard University
Рекомендации по теме
Комментарии
Автор

Will it work on _regular_ flu and cold, too?

wmverk